Richard I. Eisenstadt - 31 Jan 2023 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Chief Financial Officer
Signature
/s/ Richard Eisenstadt
Issuer symbol
ALT
Transactions as of
31 Jan 2023
Net transactions value
+$11,964
Form type
4
Filing time
02 Feb 2023, 16:09:00 UTC
Previous filing
01 Feb 2023
Next filing
24 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Award $11,964 +1,172 +11% $10.21 12,010 31 Jan 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2022 through January 31, 2023.
F2 In accordance with the ESPP, these shares were purchased based on 85% of the opening price of the issuer's common stock on August 1, 2022.